Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Hunan Institute for Drug Control, Changsha, China.
Drug Deliv. 2022 Dec;29(1):1437-1446. doi: 10.1080/10717544.2022.2072413.
Microspheres play an important role in controlling drug delivery and release rate accurately. To realize the sustainable release of insoluble small-molecule drugs, a new three-phase flow-focusing microfluidic device was developed to produce the drug-loaded sustained-release microspheres which were prepared with bicalutamide (BCS class-II) as the model drug and poly(lactide-co-glycolide) (PLGA) as the carrier material. Under optimized prescription conditions, the microspheres showed a smooth surface and uniform size of 51.33 μm with a CV value of 4.43%. Sustained-release microspheres had a releasing duration of around 40 days without any initial burst release. The drug release mechanism of the microspheres was drug diffusion and polymer erosion. Meanwhile, the drug release of microspheres could be up to 30 days. Briefly, the microfluidic device in this study provides a new solution for the preparation of sustained-release microspheres for insoluble small-molecule drugs. PLGA sustained-release microspheres developed by the microfluidic device have good application prospects in precise delivery and sustainable release of insoluble small-molecule drugs.
微球在精确控制药物释放和释放速率方面发挥着重要作用。为了实现难溶性小分子药物的持续释放,开发了一种新的三相流聚焦微流控装置来制备载药的缓释微球,以比卡鲁胺(BCS 类 II)为模型药物,聚(乳酸-共-乙醇酸)(PLGA)为载体材料。在优化的处方条件下,微球具有光滑的表面和均匀的尺寸为 51.33μm,CV 值为 4.43%。缓释微球在没有初始突释的情况下具有约 40 天的释放持续时间。微球的药物释放机制是药物扩散和聚合物侵蚀。同时,微球的药物释放可持续 30 天。总之,本研究中的微流控装置为制备难溶性小分子药物的缓释微球提供了一种新的解决方案。通过微流控装置开发的 PLGA 缓释微球在难溶性小分子药物的精确传递和持续释放方面具有良好的应用前景。